METABOLIC ASPECTS OF ANTIHYPERTENSIVE TREATMENT WITH KETANSERIN

被引：9

作者：

FERRARA, LA

FASANO, ML

SORO, S

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1985年 / 7卷 / 05期

关键词：

D O I：

10.1097/00005344-198509000-00031

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1007 / 1008

页数：2

相关论文

共 12 条

[1] ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION
AMES, RP
HILL, P
[J]. AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) : 748 - 757
[2] HYPERTENSION POTASSIUM ION AND IMPAIRED CARBOHYDRATE TOLERANCE
CONN, JW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (21) : 1135 - &
[3] EFFECT OF OXPRENOLOL AND METOPROLOL ON SERUM-LIPID CONCENTRATION
FERRARA, LA
MAROTTA, T
SCILLA, A
MASTRANZO, P
STRAZZULLO, P
MANCINI, M
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (03) : 331 - 334
[4] CARDIOVASCULAR EFFECTS OF KETANSERIN, A NEW ANTISEROTONERGIC AGENT IN THE TREATMENT OF ARTERIAL-HYPERTENSION
FERRARA, LA
FASANO, ML
SORO, S
RUBBA, P
IANNUZZI, A
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (03) : 187 - 192
[5] FERRARA LA, 1979, GIORN ARTERIOSCLER, V4, P275
[6] HYELM M, 1966, SCAND J CLIN LAB INV, V18, P85
[7] LEREN P, 1980, LANCET, V2, P4
[8] LOPASVIRELLA MF, 1977, CLIN CHEM, V23, P882
[9] ORIENTE P, 1979, CLIN ENZYMOLOGY S, V2, P387
[10] KETANSERIN IN ESSENTIAL-HYPERTENSION - EFFECTS DURING REST AND EXERCISE
PERSSON, B
HEDNER, T
BERGLUND, G
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (03) : 307 - 312